Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
01/2011
01/04/2011CA2412941C Piperidine compounds for use as ccr-3 inhibitors
01/04/2011CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
01/04/2011CA2384670C Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
01/04/2011CA2333317C Stable oil-in-glycerin emulsion
01/04/2011CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/2010
12/30/2010US20100331425 Tapentadol for Treating Pain due to Osteoarthritis
12/30/2010US20100331424 Use of Axomadol for Treatment of Arthrosis Pain
12/30/2010US20100331418 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal
12/30/2010US20100331415 Use of omega-3-fatty acid(s)
12/30/2010US20100331401 Antimicrobial and antiinflammatory composition
12/30/2010US20100331395 Decoy-containing pharmaceutical compositions and method of using the same
12/30/2010US20100331394 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure
12/30/2010US20100331386 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
12/30/2010US20100331385 Pyrazole urea derivatives used as kinase inhibitors
12/30/2010US20100331369 Therapeutic Agents Useful for Treating Pain
12/30/2010US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
12/30/2010US20100331363 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
12/30/2010US20100331359 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/30/2010US20100331357 Pharmaceutical composition
12/30/2010US20100331353 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
12/30/2010US20100331340 Use of aryl piperazine derivatives in manufacturing medicants for treating pain
12/30/2010US20100331337 Quercetin-Containing Compositions
12/30/2010US20100331333 Imidazo [1,2-B] Pyridazine Compounds
12/30/2010US20100331321 Bis-(Sulfonylamino) derivatives for use in therapy
12/30/2010US20100331319 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/30/2010US20100331315 Rhodanines and related heterocycles as kinase inhibitors
12/30/2010US20100331314 Pyrazolopyrimidines and related heterocycles as kinase inhibitors
12/30/2010US20100331306 Heterocyclic compounds and their uses
12/30/2010US20100331304 Compounds Which Modulate The CB2 Receptor
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331301 Azetidine compound and pharmaceutical use thereof
12/30/2010US20100331300 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/30/2010US20100331299 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/30/2010US20100331298 Carboxamide Compounds and Their Use
12/30/2010US20100331295 Modulators of lxr
12/30/2010US20100331294 4-substituted-2-amino-pyrimidine derivatives
12/30/2010US20100331293 Heterocyclic compounds and their uses
12/30/2010US20100331286 Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
12/30/2010US20100331285 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100331274 Antiaging Chirally-Correct Mitoprotectant Amino Acid and Peptide Complexes
12/30/2010US20100331270 Adrenomedullin production enhancer
12/30/2010US20100331269 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents
12/30/2010US20100331268 Nitrated Lipids and Methods of Making and Using Thereof
12/30/2010US20100331238 Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression
12/30/2010US20100331236 Cyclic peptides as g-protein coupled receptor antagonists
12/30/2010US20100331234 Aminoalcohol lipidoids and uses thereof
12/30/2010US20100330211 Fucoidan compositions and methods for dietary and nutritional supplements
12/30/2010US20100330209 Hair growth stimulants adn the manufacturing method thereof
12/30/2010US20100330201 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
12/30/2010US20100330198 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/30/2010US20100330197 Oral or enteral composition useful for recovery of physical functions
12/30/2010US20100330184 Injection vehicle for polymer-based formulations
12/30/2010US20100330182 Tendon Stem Cells
12/30/2010US20100330179 Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
12/30/2010US20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
12/30/2010US20100330174 Betaine compositions
12/30/2010US20100330165 Use of chemotherapeutic agents
12/30/2010US20100330159 System for transporting active substances in a biological system
12/30/2010US20100330157 Biomaterial for the controlled delivery of ingredients
12/30/2010US20100330154 amphoteric liposomes comprising neutral lipids
12/30/2010US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1
12/30/2010US20100330146 Contact lenses for extended release of bioactive agents containing diffusion attenuators
12/30/2010US20100330137 High bioavailability formulation of mangosteen and manufacturing process thereof
12/30/2010US20100330129 Gastroresistant Pharmaceutical Formulations Containing Rifaximin
12/30/2010US20100330123 Albumin-free botulinum toxin formulations
12/30/2010US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c
12/30/2010US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles
12/30/2010US20100330103 Antibodies Directed to Alpha V Beta 6 And Uses Thereof
12/30/2010US20100330094 Anti-IP-10 Antibodies and Methods of Use Thereof
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330034 Use of bispecific antibodies to regulate immune responses
12/30/2010US20100330007 Imrpoved Skin Brightening Compositions
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329996 Novel Combination of Therapeutic Agents
12/30/2010US20100329995 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
12/30/2010US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases
12/30/2010US20100329984 Respiratory dispersion for metered dose inhalers
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/29/2010WO2010151840A2 Albumin-free botulinum toxin formulations
12/29/2010WO2010151797A2 Compounds for modulating rna binding proteins and uses therefor
12/29/2010WO2010151791A1 Heterocyclic compounds and their uses
12/29/2010WO2010151784A2 Antimicrobial compounds
12/29/2010WO2010151735A2 Heterocyclic compounds and their uses
12/29/2010WO2010151281A1 Methods and kits for treating joints and soft tissues
12/29/2010WO2010151216A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
12/29/2010WO2010151095A1 Novel acetylsalicylic acid salts
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150206A1 N-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
12/29/2010WO2010150014A1 5r- 5 -deuterated glitazones for respiratory disease treatment
12/29/2010WO2010149771A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010WO2010149634A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists
12/29/2010WO2010129242A3 Treatment of osteoarthritis pain
12/29/2010WO2010078730A9 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection
12/29/2010EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject
12/29/2010EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1272